Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A receptor delta subunit (GABRD) is a specialized subunit of GABAA receptors, which are the major inhibitory neurotransmitter receptors in the mammalian brain. GABAA receptors containing the δ-subunit are primarily located extrasynaptically and mediate tonic inhibition, a slow, persistent form of inhibitory neurotransmission that differs from the rapid, phasic inhibition mediated by synaptic GABAA receptors. The δ-subunit typically assembles with specific α subunits (particularly α4, but also α1 in some brain regions) and β subunits to form functional pentameric receptors. These receptors show distinctive pharmacological properties, including high sensitivity to GABA, insensitivity to benzodiazepines, and enhanced responsiveness to ethanol and neurosteroids. The extrasynaptic localization and unique properties of δ-containing GABAA receptors make them important targets for understanding and potentially treating various neurological conditions, including alcohol use disorders, epilepsy, and pain conditions. The δ-subunit's involvement in the brain's reward pathways also suggests potential roles in addiction mechanisms and learning processes.
Modulation of chloride ion influx through the channel pore, primarily mediating tonic inhibition of neuronal activity. These receptors are benzodiazepine-insensitive.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor delta subunit (GABRD).